PeopleBio, Inc. Logo

PeopleBio, Inc.

Develops blood tests for early diagnosis of neurodegenerative diseases like Alzheimer's.

304840 | KO

Overview

Corporate Details

ISIN(s):
KR7304840002
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 판교로 242, C동 6층, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PeopleBio, Inc. is a biotechnology company specializing in the development and manufacturing of diagnostic products for protein misfolding diseases, particularly neurodegenerative conditions. The company's core innovation is its proprietary Multimer Detection System (MDS) technology, an immunoassay platform used to create simple and reliable blood tests. Its flagship product, the OAβ Test, is a blood-based diagnostic tool for the early detection of Alzheimer's disease. The test functions by measuring the oligomerization levels of beta-amyloid, a key biomarker of the disease, aiming to enable earlier diagnosis and intervention.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 00:00
Share Issue/Capital Change
전환가액의조정
Korean 13.8 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-14 00:00
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 22.0 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 25.4 KB
2025-03-20 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.9 MB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.7 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 1.1 MB
2025-03-13 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 1.1 MB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 5.1 KB
2025-02-12 00:00
Share Issue/Capital Change
전환가액의조정
Korean 13.4 KB
2024-12-13 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-22 00:00
Related Party Transaction
[기재정정]금전대여결정
Korean 21.1 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 1.3 MB

Automate Your Workflow. Get a real-time feed of all PeopleBio, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PeopleBio, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PeopleBio, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alteogen Inc. Logo
Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.
South Korea
196170
ALTERITY THERAPEUTICS LTD Logo
Developing therapies for Parkinsonian disorders and MSA by inhibiting protein aggregation.
United States of America
ATHE
Alto Neuroscience, Inc. Logo
Developing precision medicines for depression and schizophrenia using a brain biomarker platform.
United States of America
ANRO
ALUMIS INC. Logo
Develops targeted oral therapies for immune-mediated diseases using precision immunology.
United States of America
ALMS
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg
ALVO
ALX ONCOLOGY HOLDINGS INC Logo
Clinical-stage firm developing CD47 inhibitors for hematologic and solid tumors.
United States of America
ALXO
Alzamend Neuro, Inc. Logo
Developing lithium & vaccine therapies for neurodegenerative & psychiatric disorders.
United States of America
ALZN
Alzinova AB Logo
Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.
Sweden
ALZ
AMARIN CORP PLC\UK Logo
Develops prescription therapies like Vascepa® to reduce cardiovascular risk for patients.
United States of America
AMRN
AMGEN INC Logo
Biotech pioneer developing innovative human therapeutics for the world's toughest diseases.
United States of America
AMGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.